The impact of expanding health insurance coverage for anti‐cancer drugs on cancer survival in Korea

by Do‐Yeon Cho, Juhee Park, Dong‐Sook Kim
Published 2021-07-01

Determinants of Growth in Prescription Drug Spending Using 2010–2019 Health Insurance Claims Data

by HyeYeong Lee, Dahye Park, Dong-Sook Kim
Published 2021-05-01

Antibiotic use in South Korea from 2007 to 2014: A health insurance database-generated time series analysis.

by Juhee Park, Euna Han, Soo Ok Lee, Dong-Sook Kim
Published 2017-01-01

Regenerative Medicine in South Korea: Bridging the Gap Between Authorization and Reimbursement

by Dong-Sook Kim, Geunwoo Lee, Hyungyung Cho, SeungJin Bae
Published 2021-08-01

Changes of antibiotic prescribing pattern and its resistance to E. Coli in South Korea: a 12-year retrospective observational study

by Geun Woo Lee, Sukhyun Ryu, Juhee Park, Eun Jee Lee, Kwang Jun Lee, Jungyeon Tae, Youngsik Hwang, Dong-Sook Kim
Published 2021-03-01

Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study...

by Hye Sook Han, Bum Jun Kim, Hee-Jung Jee, Min-Hee Ryu, Se Hoon Park, Sun Young Rha, Jong Gwang Kim, Woo Kyun Bae, Keun-Wook Lee, Do-Youn Oh, In-Ho Kim, Sun Jin Sym, So Yeon Oh, Hyeong Su Kim, Ji-Hye Byun, Dong Sook Kim, Young Ju Suh, Hyonggin An, Dae Young Zang
Published 2021-09-01